Pharmaceuticals in Dosage Market Size Value in Mexico

The pharmaceutical dosage market in Mexico has shown a fluctuating pattern over the past decade. Starting from a peak of $12.367 billion in 2012, the market saw a consistent decline until 2016, reaching its lowest at $8.5546 billion. A gradual recovery phase followed from 2018 to 2021, with slight growth each year, but concluded with a decrease in 2022 to $8.658 billion. Analyzing the year-on-year changes, the market observed significant dips in 2013, 2014, and notably 2016, with a sharp fall of 18.25%. The most recent years, 2021 and 2022, present contrasting trends with a modest increase and a substantial drop respectively. The compound annual growth rate (CAGR) elucidates the long-term shrinkage of the market with a figure of -0.53% over the last five years.

Future trends to watch for include the aftermath of fluctuations due to global health dynamics, emerging pharmaceutical technologies, regulatory changes, and potential economic recoveries. Monitoring these factors will be crucial to anticipating the market's trajectory.